MYGN
insider transactionsMYRIAD GENETICS INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-7.5K
7.5K buy · 15.0K sell
Net value · 90d
-$39.2K
$27.6K in · $66.8K out
Sentiment · 90d
Net selling
29% buying · 71% selling
Open-market trades · 90d
2
7.5K buy · 15.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 90d
-
Sell·S
Director · 10b5-1
$66.8K
15.0K sh · $4.46
Own -8%
-
Buy·P
Director
$27.6K
7.5K sh · $3.69
Own +8%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Kumar Rashmi 10b5-1 | Sell S | 15.0K | $66.8K |
| May 14, 2026 | BISARO PAUL | Buy P | 7.5K | $27.6K |
Buy Sell Non-market (grant · exercise · gift)
About MYGN insider trading
This page tracks insider transactions for MYRIAD GENETICS INC (MYGN) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.